3-(trifluoromethyl)oxetan-3-yl 4-(5-fluoro-6-(2-methyl-6-(methylsulfonyl)pyridin-3-yloxy)pyrimidin-4-yloxy)piperidine-1-carboxylate

ID: ALA3326671

Chembl Id: CHEMBL3326671

PubChem CID: 118711779

Max Phase: Preclinical

Molecular Formula: C21H22F4N4O7S

Molecular Weight: 550.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1nc(S(C)(=O)=O)ccc1Oc1ncnc(OC2CCN(C(=O)OC3(C(F)(F)F)COC3)CC2)c1F

Standard InChI:  InChI=1S/C21H22F4N4O7S/c1-12-14(3-4-15(28-12)37(2,31)32)35-18-16(22)17(26-11-27-18)34-13-5-7-29(8-6-13)19(30)36-20(9-33-10-20)21(23,24)25/h3-4,11,13H,5-10H2,1-2H3

Standard InChI Key:  PMXJGYIIFVVUMX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3326671

    ---

Associated Targets(Human)

GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Gpr119 Glucose-dependent insulinotropic receptor (270 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 550.49Molecular Weight (Monoisotopic): 550.1145AlogP: 2.83#Rotatable Bonds: 6
Polar Surface Area: 130.04Molecular Species: NEUTRALHBA: 10HBD:
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): #RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 0.67CX LogP: 1.67CX LogD: 1.67
Aromatic Rings: 2Heavy Atoms: 37QED Weighted: 0.50Np Likeness Score: -0.88

References

1. Buzard DJ, Kim SH, Lehmann J, Han S, Calderon I, Wong A, Kawasaki A, Narayanan S, Bhat R, Gharbaoui T, Lopez L, Yue D, Whelan K, Al-Shamma H, Unett DJ, Shu HH, Tung SF, Chang S, Chuang CF, Morgan M, Sadeque A, Chu ZL, Leonard JN, Jones RM..  (2014)  Discovery and optimization of 5-fluoro-4,6-dialkoxypyrimidine GPR119 agonists.,  24  (17): [PMID:25088191] [10.1016/j.bmcl.2014.06.071]

Source